In Situ Photo Responsive Biodegradable Nanoparticle Forming Intrauterine Implant for Drug Delivery to Treat Ovarian Diseases: A Rationale-based Review
CONCLUSION: The current manuscript hypothesizes the utility of a PNP-loaded biodegradable photo-responsive intrauterine implantable device as an alternate novel strategy for ameliorating ovarian-related diseases.PMID:38031270 | DOI:10.2174/0118744710258313231105072931 (Source: Current Radiopharmaceuticals)
Source: Current Radiopharmaceuticals - November 30, 2023 Category: Radiology Authors: Leander Corrie Nagavendra Kommineni Jaskiran Kaur Ankit Awasthi Raghunandan Gundaram Latha Kukati Source Type: research
Personalized 125I Seed Interstitial Brachytherapy for Patients Aged 80 Years and Over with Early Primary High-risk Non-melanoma Skin Cancer
CONCLUSION: PISI-BT could be an alternative treatment option in patients above 80 years old with early primary high-risk NMSC and comorbidities.PMID:38018208 | DOI:10.2174/0118744710240256231103095018 (Source: Current Radiopharmaceuticals)
Source: Current Radiopharmaceuticals - November 29, 2023 Category: Radiology Authors: Liang Yansong Wang Juan Zhang Hongtao Liu Zezhou Su Xiaohua Zhao Huanfen Zhao Rongmei Yin Jianqi Source Type: research
Radioprotective Potency of Nanoceria
Curr Radiopharm. 2023 Nov 21. doi: 10.2174/0118744710267281231104170435. Online ahead of print.ABSTRACTCancer presents a significant medical challenge that requires effective management. Current cancer treatment options, such as chemotherapy, targeted therapy, radiotherapy, and immunotherapy, have limitations in terms of their efficacy and the potential harm they can cause to normal tissues. In response, researchers have been focusing on developing adjuvants that can enhance tumor responses while minimizing damage to healthy tissues. Among the promising options, nanoceria (NC), a type of nanoparticle composed of cerium oxi...
Source: Current Radiopharmaceuticals - November 22, 2023 Category: Radiology Authors: Maryam Alvandi Zahra Shaghaghi Soghra Farzipour Zeynab Marzhoseyni Source Type: research
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy
Curr Radiopharm. 2023 Nov 16. doi: 10.2174/0118744710262369231110065230. Online ahead of print.ABSTRACTRadiotherapy (RT) failure has historically been mostly attributed to radioresistance. Ferroptosis is a type of controlled cell death that depends on iron and is caused by polyunsaturated fatty acid peroxidative damage. Utilizing a ferroptosis inducer may be a successful tactic for preventing tumor growth and radiotherapy-induced cell death. A regulated form of cell death known as ferroptosis is caused by the peroxidation of phospholipids containing polyunsaturated fatty acids in an iron-dependent manner (PUFA-PLs). The fe...
Source: Current Radiopharmaceuticals - November 17, 2023 Category: Radiology Authors: Fatemeh-Jalali Zefrei Mohammd Shormij Leila Dastranj Maryam Alvandi Zahra Shaghaghi Soghra Farzipour Nasim Zarei-Polgardani Source Type: research
